YERVOY

Google image searchProduct monograph

Active ingredient

ipilimumab, 5 MG/ML

DIN: 02379384

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: FOR I.V. INFUSION ONLY. 50MG/10ML AND 200MG/40 ML SINGLE USE VIALS.

Schedule: Prescription / Schedule D

Company: BRISTOL-MYERS SQUIBB CANADA

Date: 08-MAR-2012

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FX — Other monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
• L01FX04 — IPILIMUMAB (ATC/DDD)

Reference brand drug: Yervoy

Pharmaceutical standard: MFR

External Links for Yervoy

Search on Google

• Yervoy side effects
• Yervoy dosage
• ipilimumab side effects
• ipilimumab dosage

Bristol-Myers Squibb Canada

Go to Bristol-Myers Squibb website to see drug product details. Sometimes you can find yervoy photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.